|
MTMR12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.486800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.782000E-01 |
| Normal-vs-Stage2 |
8.913000E-01 |
| Normal-vs-Stage3 |
2.336200E-01 |
| Normal-vs-Stage4 |
2.149500E-02 |
| Stage1-vs-Stage2 |
5.584600E-01 |
| Stage1-vs-Stage3 |
6.283200E-01 |
| Stage1-vs-Stage4 |
7.935800E-02 |
| Stage2-vs-Stage3 |
4.156600E-01 |
| Stage2-vs-Stage4 |
1.359370E-01 |
| Stage3-vs-Stage4 |
2.595400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.824600E-01 |
| Normal-vs-AfricanAmerican |
3.397800E-01 |
| Normal-vs-Asian |
3.707700E-02 |
| Caucasian-vs-AfricanAmerican |
6.923600E-01 |
| Caucasian-vs-Asian |
1.121430E-01 |
| AfricanAmerican-vs-Asian |
4.436400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.357700E-02 |
| Normal-vs-Female |
5.170400E-01 |
| Male-vs-Female |
7.006100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.432400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.701400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.193200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.998400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.330800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.420000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.800200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.159400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.533400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.485200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.957200E-04 |
| Classical-VS-Follicular |
1.616010E-02 |
| Classical-VS-Other |
1.177360E-01 |
| Classical-VS-Normal |
8.782000E-01 |
| Tall-VS-Follicular |
3.298800E-01 |
| Tall-VS-Other |
6.256600E-01 |
| Tall-VS-Normal |
2.117300E-03 |
| Follicular-VS-Other |
4.953200E-01 |
| Follicular-VS-Normal |
5.232000E-02 |
| Other-VS-Normal |
2.946300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.129000E-01 |
| Normal-vs-N1 |
7.56130000000299E-05 |
| N0-vs-N1 |
3.592300E-04 |
|
|
